Companies that own BioTime Inc.
Broadwood Capital, Inc.
29,971,561
23.62%
0
7.9%
06/30/2018
Greenway Partners LP
6,890,252
5.43%
0
100%
07/01/2018
BlackRock Fund Advisors
5,403,396
4.26%
477,234
0%
06/30/2018
The Vanguard Group, Inc.
4,332,348
3.42%
224,559
0%
06/30/2018
AXA Investment Managers UK Ltd.
2,301,657
1.81%
13,881
0.02%
06/30/2018
SSgA Funds Management, Inc.
2,228,370
1.76%
181,019
0%
06/30/2018
Prescott Investors, Inc.
1,851,851
1.46%
0
0.16%
06/30/2018
British & American Investment Trust Plc (Invt Mgmt)
1,525,776
1.2%
55,694
13.56%
12/31/2017
Geode Capital Management LLC
1,161,423
0.92%
53,786
0%
06/30/2018
Northern Trust Investments, Inc.
1,016,226
0.8%
49,778
0%
06/30/2018
| Address |
1010 Atlantic Avenue
Alameda California 94501
United States
|
|
Employees
|
- |
| Website |
http://www.biotimeinc.com |
| Updated |
07/08/2019 |
| BioTime, Inc. is a clinical-stage biotechnology company, which deals with degenerative diseases. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. |
